Manuela Spadea: Celebrating Recognition for Pediatric HSCT Research at EHA 2026
Manuela Spadea, Assistant Professor of Pediatrics at University of Turi, shared a post on LinkedIn:
“Grateful that our European Hematology Association (EHA) 2026 poster was selected as one of the top-scoring abstracts and received a travel grant to attend the Congress in Stockholm.
Presenting and discussing our work on early risk stratification after pediatric allogeneic HSCT was a real pleasure.
This is a setting where fever and inflammation can indicate very different clinical paths, ranging from benign febrile neutropenia to infectious or endothelial-driven transplant-related complications.
Importantly, the research is still underway.
We are refining the analyses to enhance statistical power, improve clinical relevance, and better understand how Pro-ADM can aid in risk-based monitoring and decision-making in pediatric HSCT.
A heartfelt thank you to all the co-authors, participating centers, clinical teams, clinical trial office colleagues, patients, and families who made this collaborative effort possible.”

Stay updated with Hemostasis Today.
-
Jun 14, 2026, 08:17Amber Yates: Honoring the Sickle Cell Community Behind the Rise Up Study
-
Jun 14, 2026, 06:19Sharmila Manian: World Blood Donor Day – Where Generosity Meets Smart Medicine
-
Jun 14, 2026, 06:04Vishnu R.: FedServ Employees Unite to Save Lives Through Blood Donation
-
Jun 13, 2026, 20:28Tarun Tyagi: Translational Insights into Severe Immune Thrombocytopenia
-
Jun 13, 2026, 18:25Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
-
Jun 13, 2026, 18:24Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 18:21Thomas Stauch: Discussing the Future of ITP Research and Patient Care